Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q2
Sell
-30,100
Closed -$1.28M 133
2017
Q1
$1.28M Sell
30,100
-26,700
-47% -$1.09M 0.29% 89
2016
Q4
$2.28M Sell
56,800
-5,000
-8% -$193K 0.62% 53
2016
Q3
$2.4M Hold
61,800
0.67% 56
2016
Q2
$2.14M Hold
61,800
0.66% 56
2016
Q1
$2.13M Hold
61,800
0.6% 50
2015
Q4
$2.39M Sell
61,800
-10,100
-14% -$393K 0.61% 56
2015
Q3
$2.81M Sell
71,900
-32,500
-31% -$1.29M 0.76% 50
2015
Q2
$3.97M Sell
104,400
-16,000
-13% -$560K 1.06% 35
2015
Q1
$3.98M Sell
120,400
-43,100
-26% -$1.32M 0.88% 37
2014
Q4
$4.37M Buy
163,500
+47,000
+40% +$1.21M 0.88% 31
2014
Q3
$2.83M Buy
116,500
+80,000
+219% +$2.02M 0.65% 45
2014
Q2
$925K Sell
36,500
-20,500
-36% -$479K 0.22% 96
2014
Q1
$1.23M Buy
+57,000
New +$1.23M 0.32% 83

Other funds holding HOLX

Continental Advisors's HOLX Position: Q2 2017 in Review

Continental Advisors sold out of Hologic (HOLX) in Q2 2017, closing a stake of 30,100 shares — an estimated $1.28M sold.

Continental Advisors first reported a position in HOLX in Q1 2014 and held it in 13 quarters. The position peaked at $4.37M in Q4 2014. 505 funds tracked by Wall St. Rank hold HOLX as of Q2 2017.

  • Continental Advisors reported no remaining Hologic position as of Q2 2017 after selling out during the quarter.
  • Continental Advisors sold 30,100 Hologic shares in Q2 2017, an estimated $1.28M.
  • Continental Advisors first reported a position in Hologic in Q1 2014 and held it in 13 quarters.
  • Continental Advisors's Hologic position peaked at $4.37M in Q4 2014.
  • 505 funds tracked by Wall St. Rank held Hologic as of Q2 2017.

Based on Continental Advisors's 13F filing for Q2 2017, filed 14 Aug 2017.